These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 5258856

  • 1. [Excretion of beta-aminoisobutyric acid in health, in systemic lupus erythematosus and leukemia].
    Mazurik VK, Kondrat'eva AP, Bryskina LE, Nasonova VA.
    Vopr Med Khim; 1969; 15(1):70-5. PubMed ID: 5258856
    [No Abstract] [Full Text] [Related]

  • 2. [Urinary elimination of beta aminoisobutyric acid in malignant hemopathies].
    Roulaud F, Boisseau M, Moreau F, Labatut M.
    C R Seances Soc Biol Fil; 1971; 165(1):83-7. PubMed ID: 4257756
    [No Abstract] [Full Text] [Related]

  • 3. Urinary amino acid excretion in subjects with leukaemia.
    Lee MB, Neill DW, Bridges JM.
    J Clin Pathol; 1967 Jan; 20(1):70-4. PubMed ID: 5225727
    [Abstract] [Full Text] [Related]

  • 4. Urinary polyamines in cancer patients.
    Russell DH, Levy CC, Schimpff SC, Hawk IA.
    Cancer Res; 1971 Nov; 31(11):1555-8. PubMed ID: 4941348
    [No Abstract] [Full Text] [Related]

  • 5. [Biochemical findings in body fluids in leukemia patients. Changes in the urine].
    Ledvina M.
    Z Gesamte Inn Med; 1967 Jul 15; 22(14):409-15. PubMed ID: 4233203
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Urinary excretion of glycosaminoglycans in malignant diseases of the haemopoietic and lymphatic tissues.
    Friman C, Juvani M.
    Acta Med Scand; 1975 Jul 15; 198(1-2):115-22. PubMed ID: 126635
    [Abstract] [Full Text] [Related]

  • 8. [Changes in polyamine excretion during the treatment of patients with chronic leukemias].
    Voronchikhina LD, Zinkovskiĭ IuV, Berdnikova TI, Berdinskikh NK.
    Probl Gematol Pereliv Krovi; 1982 Sep 15; 27(9):25-8. PubMed ID: 6960346
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Beta trace protein. Purification and urinary excretion studies in selected diseases.
    Whitsed H, Penny R.
    Clin Chim Acta; 1974 Jan 19; 50(1):111-8. PubMed ID: 4205928
    [No Abstract] [Full Text] [Related]

  • 11. Urinary excretion of beta-aminoisobutyrate and pseudouridine in acute and chronic myeloid leukemia.
    Nielsen HR, Killmann SA.
    J Natl Cancer Inst; 1983 Nov 19; 71(5):887-91. PubMed ID: 6580488
    [Abstract] [Full Text] [Related]

  • 12. Granulocyte colony stimulating activity and vitamin B12 binding proteins in human urine.
    Gibson EL, Herbert V, Robinson WA.
    Br J Haematol; 1974 Oct 19; 28(2):191-7. PubMed ID: 4530730
    [No Abstract] [Full Text] [Related]

  • 13. Systemic lupus erythematosus preceding acute lymphoblastic leukemia.
    Kletzel M, Melloni L, Terrez A, Rosenthal J.
    J Ark Med Soc; 1986 Apr 19; 82(11):563-5. PubMed ID: 2940223
    [No Abstract] [Full Text] [Related]

  • 14. [Utilization of "anti-serum specific" immune serums for the study of abnormal circulating proteins (in acute leukemia, Hodgkin's disease and disseminated lupus erythematosus)].
    CAETANO JA, da COSTA S, SOARES AD, da SILVA J.
    Gaz Med Port; 1960 Apr 19; 13():575-82. PubMed ID: 13689743
    [No Abstract] [Full Text] [Related]

  • 15. Normalizing effect of prednisone on excessive hydroxyprolinuria in active systemic lupus erythematosus.
    Cieślicka T.
    Mater Med Pol; 1976 Apr 19; 8(4):448-52. PubMed ID: 1027962
    [No Abstract] [Full Text] [Related]

  • 16. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
    Mitarnun W, Pradutkanchana J, Takao S, Saechan V, Suwiwat S, Ishida T.
    J Med Assoc Thai; 2002 May 19; 85(5):552-9. PubMed ID: 12188384
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Vitamin B 12-binding glycoproteins. IV. Co57-cyanocobalamin binding capacity of urine in various blood diseases and multiple sclerosis7 9].
    Kallee E, Castrillón-Oberndorfer, Feine U, Finke J.
    Klin Wochenschr; 1966 Jul 15; 44(14):845. PubMed ID: 5239383
    [No Abstract] [Full Text] [Related]

  • 19. [HL-A system and human diseases].
    Amiel JL.
    Presse Med (1893); 1971 Mar 20; 79(14):615-6. PubMed ID: 4324152
    [No Abstract] [Full Text] [Related]

  • 20. Increased urinary beta 2-microglobulin after cancer chemotherapy.
    Fleming JJ, Parapia L, Morgan DB, Child JA.
    Cancer Treat Rep; 1980 Mar 20; 64(4-5):581-8. PubMed ID: 6159076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.